EcoDrugPlus

Stromelysin-1

Ensembl ID : ENSMPUG00000006864
Gene Symbol: LOC101688701
2 Cross references
487 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSMPUG00000009641
Gene Symbol: SI
4 Cross references
200 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSMPUG00000008365
Gene Symbol: TACR1
4 Cross references
267 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSMPUG00000004421
Gene Symbol: TACR2
2 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSMPUG00000009183
Gene Symbol: TACR3
2 Cross references
256 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSMPUG00000008917
Gene Symbol: TERT
4 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSMPUG00000003737
Gene Symbol: TBXAS1
2 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSMPUG00000004032
Gene Symbol: TBXA2R
2 Cross references
192 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSMPUG00000005419
Gene Symbol: TYMS
2 Cross references
224 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSMPUG00000012135
Gene Symbol: THRB
4 Cross references
392 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSMPUG00000005893
Gene Symbol: TRHR
2 Cross references
266 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSMPUG00000018894
Gene Symbol: TLR2
2 Cross references
251 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).